Amylyx Pharmaceuticals, Inc. AMLX Market capitalization

Market capitalization at other companies

MBX Biosciences, Inc.MBX

$1.42B+475%

Viking TherapeuticsVKTX

$3.76B+38.7%

Crinetics PharmaceuticalsCRNX

$3.8B+21.9%

VAN

Vivani MedicalVANI

$84.65M+21.0%

uniQureQURE

$3.17B+307%

MeiraGTx Holdings plcMGTX

$705.32M+31.9%

FAQ

What is Amylyx Pharmaceuticals, Inc.'s market capitalization?

Amylyx Pharmaceuticals, Inc. (AMLX) reported market capitalization of $2B in Q2 2026.

How has Amylyx Pharmaceuticals, Inc.'s market capitalization changed year-over-year?

Amylyx Pharmaceuticals, Inc.'s market capitalization increased by 249.5% year-over-year, from $571.39M to $2B.

What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s market capitalization?

Over 3 years (2022 to 2025), Amylyx Pharmaceuticals, Inc.'s market capitalization has grown at a -18.1% compound annual growth rate (CAGR), from $2.42B to $1.33B.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.